Sonesitatug vedotin reduced the risk of death by 42% in 2nd and later-line CLDN18.2-positive advanced gas cancer/GEJ in CLARITY-Gastric01 - announced the company - FT.com.
Sonesitatug vedotin reduced the risk of death by 42% in 2nd and later-line CLDN18.2-positive advanced gas cancer/GEJ in CLARITY-Gastric01 - announced the company - FT.com.